Concord Medical Services Holdings Limited
CCM
$8.20
-$0.51-5.86%
NYSE
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.48M | 11.53M | 17.51M | 20.30M | 20.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.48M | 11.53M | 17.51M | 20.30M | 20.79M |
| Cost of Revenue | 14.09M | 14.16M | 20.23M | 22.97M | 23.53M |
| Gross Profit | -2.61M | -2.62M | -2.71M | -2.67M | -2.73M |
| SG&A Expenses | 20.63M | 20.73M | 14.53M | 12.60M | 12.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.72M | 34.89M | 34.75M | 35.57M | 36.43M |
| Operating Income | -23.24M | -23.36M | -17.24M | -15.27M | -15.64M |
| Income Before Tax | -23.09M | -23.20M | -22.29M | -16.68M | -17.08M |
| Income Tax Expenses | -613.80K | -616.80K | -80.10K | -1.67M | -1.71M |
| Earnings from Continuing Operations | -22.48M | -22.59M | -22.21M | -15.01M | -15.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 13.02M | 13.09M | 7.89M | 8.52M | 8.72M |
| Net Income | -9.45M | -9.50M | -14.31M | -6.49M | -6.65M |
| EBIT | -23.24M | -23.36M | -17.24M | -15.27M | -15.64M |
| EBITDA | -19.03M | -19.21M | -13.13M | -10.88M | -11.14M |
| EPS Basic | -64.91 | -65.23 | -98.29 | -44.59 | -45.66 |
| Normalized Basic EPS | -0.33 | -0.33 | -1.37 | -- | -- |
| EPS Diluted | -65.19 | -65.50 | -98.55 | -44.59 | -45.66 |
| Normalized Diluted EPS | -0.33 | -0.33 | -1.37 | -- | -- |
| Average Basic Shares Outstanding | 4.37M | 4.37M | 4.37M | 4.37M | 4.37M |
| Average Diluted Shares Outstanding | 145.60K | 145.60K | 145.60K | 145.60K | 145.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |